Avivagen Inc. (TSXV:VIV) - CEO, Kym Anthony.
CEO, Kym Anthony.
Source: YouTube
  • Avivagen Inc. (VIV) it has signed a distribution agreement with Nong San Viet Co. Ltd to expand its oxidized carotenoid-based feed additive product in Vietnam
  • Avivagen is a life sciences corporation enhancing livestock feed
  • Its OxC-betaTM technology provides a non-antibiotic means of promoting health
  • Avivagen believes Vietnam will surpass 35 million tonnes of feed in the next few years
  • Avivagen Inc. (VIV) is down 2.38 per cent trading at $0.20 per share as of 12:00 p.m. ET

Avivagen (VIV) has signed a distribution agreement with Nong San Viet Co Ltd.

Under the agreement, Avivagen will partner with Nong San Viet Co. Ltd. to expand its oxidized carotenoid-based feed additive product in Vietnam.

Avivagen is a life sciences corporation developing and commercializing products for livestock, companion animals, and human applications that enhance feed intake and support immune function. Nong San Viet is a distributor of feed ingredients and feed additives to major producers throughout Vietnam.

Avivagen’s feed additive technology, OxC-beta™, is derived from compounds that contribute to certain fruits and vegetables bright colours. The company’s technology provides a non-antibiotic means of promoting health and growth.

OxC-beta™ Livestock is a proprietary product that Avivagen states have shown to be an effective and economical alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the U.S., Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, and Malaysia.

Avivagen stated that its OxC-beta™ Livestock product is safe and effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Multiple international trials with poultry and swine using the product proved it performs as well as other in-feed antibiotics.

“We’ve seen strong interest from producers across Vietnam since receiving regulatory approval earlier this year and hope to see equally strong results from this new relationship over the coming months and years,” Kym Anthony, CEO of Avivagen, said.

According to Aviva, Vietnam is the largest feed market in Southeast Asia, with a total annual feed consumption of over 32 million tonnes in 2020. The company believes Vietnam will surpass 35 million tonnes of feed within the next few years. 

Avivagen Inc. (VIV) is down 2.38 per cent trading at $0.20 per share as of 12:00 p.m. ET.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.